---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290823995.md"
description: "Passage Bio shares are trading higher after the company announced it entered into a definitive merger agreement with Remix Therapeutics."
datetime: "2026-06-24T20:43:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290823995.md)
  - [en](https://longbridge.com/en/news/290823995.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290823995.md)
---

# 

Passage Bio shares are trading higher after the company announced it entered into a definitive merger agreement with Remix Therapeutics.

### Related Stocks

- [PASG.US](https://longbridge.com/en/quote/PASG.US.md)

## Related News & Research

- [Passage Bio agrees to merge with Remix Therapeutics in all-stock deal](https://longbridge.com/en/news/290733739.md)
- [Lynx1 Capital Management Discloses Investment at Passage BIO with 21.0% Stake](https://longbridge.com/en/news/291607457.md)
- [Kalaris Therapeutics’ Amy O’Leary Vandekop, associate VP and corporate controller, files initial beneficial ownership statement](https://longbridge.com/en/news/293969051.md)
- [Elicera Therapeutics CEO Jamal El-Mosleh to step down in October 2026, search begins](https://longbridge.com/en/news/293708688.md)
- [ADAR1 Capital Management LLC Sells 129,437 Shares of Maze Therapeutics, Inc. $MAZE](https://longbridge.com/en/news/294165839.md)